{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T12:52:20Z","timestamp":1780404740302,"version":"3.54.1"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T00:00:00Z","timestamp":1720137600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Infection"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s15010-024-02279-w","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T14:23:17Z","timestamp":1720189397000},"page":"2297-2314","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Evaluation and implementation of optimized antimicrobial dosing strategies in obese and underweight patients"],"prefix":"10.1007","volume":"52","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-9184-7535","authenticated-orcid":false,"given":"Valerie","family":"Caubergs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1425-556X","authenticated-orcid":false,"given":"Evelyne","family":"Van den Broucke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1501-3045","authenticated-orcid":false,"given":"Beatrijs","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1378-3772","authenticated-orcid":false,"given":"Matthias","family":"Gijsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6974-8493","authenticated-orcid":false,"given":"Willy E.","family":"Peetermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-099X","authenticated-orcid":false,"given":"Eric","family":"Van Wijngaerden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4338-1929","authenticated-orcid":false,"given":"Stefanie","family":"Desmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8668-1350","authenticated-orcid":false,"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6338-2355","authenticated-orcid":false,"given":"Peter","family":"Declercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6072-2596","authenticated-orcid":false,"given":"Charlotte","family":"Quintens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6342-0676","authenticated-orcid":false,"given":"Isabel","family":"Spriet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,7,5]]},"reference":[{"issue":"10325","key":"2279_CR1","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","volume":"399","author":"CJ Murray","year":"2022","unstructured":"Murray CJ, et al. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399(10325):629\u201355. https:\/\/doi.org\/10.1016\/S0140-6736(21)02724-0.","journal-title":"Lancet"},{"key":"2279_CR2","unstructured":"World Health Organization, \u201cAntimicrobial resistance,\u201d World Health Organization. Accessed 30 Mar 2023. [Online]. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/antimicrobial-resistance"},{"key":"2279_CR3","unstructured":"World Health Organization, \u201cObesity and overweight,\u201d World Health Organization. Accessed 11 Jan 2023. [Online]. Available: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight"},{"key":"2279_CR4","unstructured":"World Health Organization, \u201cA healthy lifestyle - WHO recommendations,\u201d World Health Organization. Accessed 11 Jan 2023. [Online]. Available: https:\/\/www.who.int\/europe\/news-room\/fact-sheets\/item\/a-healthy-lifestyle---who-recommendations"},{"key":"2279_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1136340","author":"M Volpe","year":"2023","unstructured":"Volpe M, Gallo G. Obesity and cardiovascular disease: an executive document on pathophysiological and clinical links promoted by the Italian society of cardiovascular prevention (SIPREC). Front Cardiovasc Med. 2023. https:\/\/doi.org\/10.3389\/fcvm.2023.1136340.","journal-title":"Front Cardiovasc Med"},{"issue":"12","key":"2279_CR6","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1007\/s001980070026","volume":"11","author":"A Coin","year":"2001","unstructured":"Coin A, et al. Bone mineral density and body composition in underweight and normal elderly subjects. Osteoporos Int. 2001;11(12):1043\u201350. https:\/\/doi.org\/10.1007\/s001980070026.","journal-title":"Osteoporos Int"},{"issue":"23","key":"2279_CR7","doi-asserted-by":"publisher","first-page":"00081","DOI":"10.1016\/j.spinee.2023.02.015","volume":"S1529\u20139430","author":"J Park","year":"2023","unstructured":"Park J, Han S, Jang H-D, Shin G, Han K, Hong J-Y. Underweight as a risk factor for vertebral fractures in the South Korean population. Spine J. 2023;S1529\u20139430(23):00081\u20135. https:\/\/doi.org\/10.1016\/j.spinee.2023.02.015.","journal-title":"Spine J"},{"issue":"4","key":"2279_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ijantimicag.2016.01.009","volume":"47","author":"AS Alobaid","year":"2016","unstructured":"Alobaid AS, Hites M, Lipman J, Taccone FS, Roberts JA. Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: a structured review. Int J Antimicrob Agents. 2016;47(4):259\u201368. https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.01.009.","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"2279_CR9","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1002\/pds.3461","volume":"22","author":"C Longo","year":"2013","unstructured":"Longo C, et al. The effect of obesity on antibiotic treatment failure: a historical cohort study. Pharmacoepidemiol Drug Saf. 2013;22(9):970\u20136. https:\/\/doi.org\/10.1002\/pds.3461.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"2279_CR10","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jinf.2012.03.013","volume":"65","author":"J Halilovic","year":"2012","unstructured":"Halilovic J, Heintz BH, Brown J. Risk factors for clinical failure in patients hospitalized with cellulitis and cutaneous abscess. J Infect. 2012;65(2):128\u201334. https:\/\/doi.org\/10.1016\/j.jinf.2012.03.013.","journal-title":"J Infect"},{"issue":"11","key":"2279_CR11","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1007\/s11695-008-9477-z","volume":"18","author":"M Abdullahi","year":"2008","unstructured":"Abdullahi M, et al. The eradication of Helicobacter pylori is affected by body mass index (BMI). Obes Surg. 2008;18(11):1450\u20134. https:\/\/doi.org\/10.1007\/s11695-008-9477-z.","journal-title":"Obes Surg"},{"issue":"3","key":"2279_CR12","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1111\/j.1467-789X.2008.00546.x","volume":"10","author":"ME Falagas","year":"2009","unstructured":"Falagas ME, Athanasoulia AP, Peppas G, Karageorgopoulos DE. Effect of body mass index on the outcome of infections: a systematic review. Obes Rev. 2009;10(3):280\u20139. https:\/\/doi.org\/10.1111\/j.1467-789X.2008.00546.x.","journal-title":"Obes Rev"},{"issue":"5","key":"2279_CR13","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2165\/00003088-200038050-00003","volume":"38","author":"DT Bearden","year":"2000","unstructured":"Bearden DT, Rodvold KA. Dosage adjustments for antibacterials in obese patients. Clin Pharmacokinet. 2000;38(5):415\u201326. https:\/\/doi.org\/10.2165\/00003088-200038050-00003.","journal-title":"Clin Pharmacokinet"},{"key":"2279_CR14","unstructured":"European Medicines Agency, \u201cPharmacokinetic Studies in Man,\u201d 1988. Accessed 30 Mar 2023. [Online]. Available: https:\/\/www.ema.europa.eu\/en\/pharmacokinetic-studies-man-scientific-guideline"},{"key":"2279_CR15","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration, \u201cPopulation Pharmacokinetics Guidance for Industry,\u201d Silver Springs, Feb. 2022. Accessed 13 Apr 2023. [Online]. Available: https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/population-pharmacokinetics"},{"issue":"3","key":"2279_CR16","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.idc.2007.07.004","volume":"21","author":"SJ Bergman","year":"2007","unstructured":"Bergman SJ, Speil C, Short M, Koirala J. Pharmacokinetic and pharmacodynamic aspects of antibiotic use in high-risk populations. Infect Dis Clin North Am. 2007;21(3):821\u201346. https:\/\/doi.org\/10.1016\/j.idc.2007.07.004.","journal-title":"Infect Dis Clin North Am"},{"issue":"8","key":"2279_CR17","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1093\/jac\/dkac160","volume":"77","author":"L Chen","year":"2022","unstructured":"Chen L, et al. Total bodyweight and sex both drive pharmacokinetic variability of fluconazole in obese adults. J Antimicrob Chemother. 2022;77(8):2217\u201326. https:\/\/doi.org\/10.1093\/jac\/dkac160.","journal-title":"J Antimicrob Chemother"},{"issue":"4","key":"2279_CR18","doi-asserted-by":"publisher","first-page":"R126","DOI":"10.1186\/cc9091","volume":"14","author":"FS Taccone","year":"2010","unstructured":"Taccone FS, et al. Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock. Crit Care. 2010;14(4):R126. https:\/\/doi.org\/10.1186\/cc9091.","journal-title":"Crit Care"},{"issue":"1","key":"2279_CR19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s13054-023-04353-5","volume":"27","author":"SD Meenks","year":"2023","unstructured":"Meenks SD, Punt N, le Noble JLML, Foudraine NA, Neef K, Janssen PKC. Target attainment and population pharmacokinetics of flucloxacillin in critically ill patients: a multicenter study. Crit Care. 2023;27(1):82. https:\/\/doi.org\/10.1186\/s13054-023-04353-5.","journal-title":"Crit Care"},{"issue":"6","key":"2279_CR20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/sdi.12972","volume":"34","author":"SM Jang","year":"2021","unstructured":"Jang SM, Awdishu L. Drug dosing considerations in continuous renal replacement therapy. Semin Dial. 2021;34(6):480\u20138. https:\/\/doi.org\/10.1111\/sdi.12972.","journal-title":"Semin Dial"},{"issue":"3","key":"2279_CR21","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/phar.2771","volume":"43","author":"C Wang","year":"2023","unstructured":"Wang C, et al. Determination of vancomycin exposure target and individualized dosing recommendations for critically ill patients undergoing continuous renal replacement therapy. Pharmacotherapy. 2023;43(3):180\u20138. https:\/\/doi.org\/10.1002\/phar.2771.","journal-title":"Pharmacotherapy"},{"issue":"10","key":"2279_CR22","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1007\/s00134-022-06847-2","volume":"48","author":"JA Roberts","year":"2022","unstructured":"Roberts JA, et al. Machines that help machines to help patients: optimising antimicrobial dosing in patients receiving extracorporeal membrane oxygenation and renal replacement therapy using dosing software. Intensive Care Med. 2022;48(10):1338\u201351. https:\/\/doi.org\/10.1007\/s00134-022-06847-2.","journal-title":"Intensive Care Med"},{"issue":"1","key":"2279_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/11318140-000000000-00000","volume":"49","author":"AA Udy","year":"2010","unstructured":"Udy AA, Roberts JA, Boots RJ, Paterson DL, Lipman J. Augmented renal clearance. Clin Pharmacokinet. 2010;49(1):1\u201316. https:\/\/doi.org\/10.2165\/11318140-000000000-00000.","journal-title":"Clin Pharmacokinet"},{"key":"2279_CR24","unstructured":"The European Committee on Antimicrobial Susceptibility Testing, \u201cBreakpoint tables for interpretation of MICs and zone diameters,\u201d Version 13, 2023. Accessed 03 Apr 2023. [Online]. Available: https:\/\/www.eucast.org\/clinical_breakpoints"},{"issue":"5","key":"2279_CR25","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/apm.12951","volume":"127","author":"C Moser","year":"2019","unstructured":"Moser C, et al. Antibiotic therapy as personalized medicine \u2013 general considerations and complicating factors. APMIS. 2019;127(5):361\u201371. https:\/\/doi.org\/10.1111\/apm.12951.","journal-title":"APMIS"},{"issue":"6","key":"2279_CR26","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1111\/jcpt.12200","volume":"39","author":"AK Polso","year":"2014","unstructured":"Polso AK, Lassiter JL, Nagel JL. Impact of hospital guideline for weight-based antimicrobial dosing in morbidly obese adults and comprehensive literature review. J Clin Pharm Ther. 2014;39(6):584\u2013608. https:\/\/doi.org\/10.1111\/jcpt.12200.","journal-title":"J Clin Pharm Ther"},{"issue":"1","key":"2279_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12911-019-0748-5","volume":"19","author":"C Quintens","year":"2019","unstructured":"Quintens C, et al. Development and implementation of \u2018check of medication appropriateness\u2019 (CMA): advanced pharmacotherapy-related clinical rules to support medication surveillance. BMC Med Inform Decis Mak. 2019;19(1):29. https:\/\/doi.org\/10.1186\/s12911-019-0748-5.","journal-title":"BMC Med Inform Decis Mak"},{"issue":"1","key":"2279_CR28","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1093\/jac\/dkab364","volume":"77","author":"C Quintens","year":"2022","unstructured":"Quintens C, et al. The effectiveness of check of medication appropriateness for antimicrobial stewardship: an interrupted time series analysis. J Antimicrob Chemother. 2022;77(1):259\u201367. https:\/\/doi.org\/10.1093\/jac\/dkab364.","journal-title":"J Antimicrob Chemother"},{"key":"2279_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2021-053010","author":"C Quintens","year":"2022","unstructured":"Quintens C, Coenen M, Declercq P, Casteels M, Peetermans WE, Spriet I. From basic to advanced computerised intravenous to oral switch for paracetamol and antibiotics: an interrupted time series analysis. BMJ Open. 2022. https:\/\/doi.org\/10.1136\/bmjopen-2021-053010.","journal-title":"BMJ Open"},{"issue":"6","key":"2279_CR30","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1111\/cob.12076","volume":"4","author":"CE Tucker","year":"2014","unstructured":"Tucker CE, Lockwood AM, Nguyen NH. Antibiotic dosing in obesity: the search for optimum dosing strategies. Clin Obes. 2014;4(6):287\u201395. https:\/\/doi.org\/10.1111\/cob.12076.","journal-title":"Clin Obes"},{"issue":"7","key":"2279_CR31","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1586\/14787210.2014.912942","volume":"12","author":"KD Payne","year":"2014","unstructured":"Payne KD, Hall RG. Dosing of antibacterial agents in obese adults: does one size fit all? Expert Rev Anti Infect Ther. 2014;12(7):829\u201354. https:\/\/doi.org\/10.1586\/14787210.2014.912942.","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"11","key":"2279_CR32","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1002\/phar.2023","volume":"37","author":"L Meng","year":"2017","unstructured":"Meng L, Mui E, Holubar MK, Deresinski SC. Comprehensive guidance for antibiotic dosing in obese adults. Pharmacotherapy. 2017;37(11):1415\u201331. https:\/\/doi.org\/10.1002\/phar.2023.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"2279_CR33","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1097\/QCO.0b013e328359a4c1","volume":"25","author":"B Janson","year":"2012","unstructured":"Janson B, Thursky K. Dosing of antibiotics in obesity. Curr Opin Infect Dis. 2012;25(6):634\u201349. https:\/\/doi.org\/10.1097\/QCO.0b013e328359a4c1.","journal-title":"Curr Opin Infect Dis"},{"issue":"3","key":"2279_CR34","doi-asserted-by":"publisher","first-page":"195","DOI":"10.2146\/ajhp120568","volume":"70","author":"DW Bratzler","year":"2013","unstructured":"Bratzler DW, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013;70(3):195\u2013283. https:\/\/doi.org\/10.2146\/ajhp120568.","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"2279_CR35","doi-asserted-by":"publisher","first-page":"e162","DOI":"10.1002\/phar.1470","volume":"34","author":"ND Lopez","year":"2014","unstructured":"Lopez ND, Phillips KM. Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration. Pharmacotherapy. 2014;34(9):e162\u20138. https:\/\/doi.org\/10.1002\/phar.1470.","journal-title":"Pharmacotherapy"},{"key":"2279_CR36","unstructured":"Nederlands Kenniscentrum voor Farmacotherapie bij Kinderen, \u201cKinderformularium.\u201d Accessed 31 Mar 2023. [Online]. Available: https:\/\/www.kinderformularium.nl\/"},{"issue":"10","key":"2279_CR37","doi-asserted-by":"publisher","first-page":"2909","DOI":"10.1093\/jac\/dkw226","volume":"71","author":"F de Velde","year":"2016","unstructured":"de Velde F, de Winter BCM, Koch BCP, van Gelder T, Mouton JW. Non-linear absorption pharmacokinetics of amoxicillin: consequences for dosing regimens and clinical breakpoints. J Antimicrob Chemother. 2016;71(10):2909\u201317. https:\/\/doi.org\/10.1093\/jac\/dkw226.","journal-title":"J Antimicrob Chemother"},{"key":"2279_CR38","unstructured":"The European Committee on Antimicrobial Susceptibility Testing, \u201cNew S, I and R definitions,\u201d EUCAST. Accessed 03 Apr 2023. [Online]. Available: https:\/\/www.eucast.org\/newsiandr"},{"issue":"3","key":"2279_CR39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1002\/phar.2769","volume":"43","author":"L Meng","year":"2023","unstructured":"Meng L, Mui E, Ha DR, Stave C, Deresinski SC, Holubar M. Comprehensive guidance for antibiotic dosing in obese adults: 2022 update. Pharmacotherapy. 2023;43(3):226\u201346. https:\/\/doi.org\/10.1002\/phar.2769.","journal-title":"Pharmacotherapy"},{"issue":"4","key":"2279_CR40","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1046\/j.1365-2710.2002.00430.x","volume":"27","author":"AK Wagner","year":"2002","unstructured":"Wagner AK, Soumerai SB, Zhang F, Ross-Degnan D. Segmented regression analysis of interrupted time series studies in medication use research. J Clin Pharm Ther. 2002;27(4):299\u2013309. https:\/\/doi.org\/10.1046\/j.1365-2710.2002.00430.x.","journal-title":"J Clin Pharm Ther"}],"container-title":["Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02279-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s15010-024-02279-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s15010-024-02279-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,5]],"date-time":"2024-12-05T19:04:50Z","timestamp":1733425490000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s15010-024-02279-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,5]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["2279"],"URL":"https:\/\/doi.org\/10.1007\/s15010-024-02279-w","relation":{},"ISSN":["0300-8126","1439-0973"],"issn-type":[{"value":"0300-8126","type":"print"},{"value":"1439-0973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,5]]},"assertion":[{"value":"15 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"I declare that the authors have no competing interests as defined by Springer, or other interests that might be perceived to influence the results and\/or discussion reported in this paper. The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study involves human participants and was approved by the institutional and\/or national research committee (Ethics Committee Research UZ Leuven, Belgium; S61615). Pharmacist recommendations were provided to the treating physician, who finally had to decide on treatment adaptation. Patients were therefore not obliged to provide informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}